Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment.
Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment.
复制标题
DOI:
10.1016/j.ccell.2021.09.005
复制
发表时间:
2021-11-08
期刊:
影响因子:
50.3
通讯作者:
as part of the Boston Bone Metastases Consortium
中科院分区:
文献类型:
--
作者:
Kfoury Y;Baryawno N;Severe N;Mei S;Gustafsson K;Hirz T;Brouse T;Scadden EW;Igolkina AA;Kokkaliaris K;Choi BD;Barkas N;Randolph MA;Shin JH;Saylor PJ;Scadden DT;Sykes DB;Kharchenko PV;as part of the Boston Bone Metastases Consortium
Bone metastases are devastating complications of cancer. They are particularly common in prostate cancer (PCa), represent incurable disease and are refractory to immunotherapy. We seek to define distinct features of the bone marrow (BM) microenvironment by analyzing single cells from bone metastatic prostate tumors, involved BM, uninvolved BM as well as BM from cancer-free, orthopedic patients and healthy individuals. Metastatic PCa is associated with multifaceted immune distortion, specifically exhaustion of distinct T cell subsets, appearance of macrophages with states specific to PCa bone metastases. The chemokine CCL20 is notably overexpressed by myeloid cells, as is its cognate CCR6 receptor on T cells. Disruption of the CCL20-CCR6 axis in mice with syngeneic PCa bone metastases restores T cell reactivity and significantly prolongs animal survival. Comparative high-resolution analysis of PCa bone metastases shows a targeted approach for relieving local immunosuppression for therapeutic effect. Kfoury et al., identify an immune-suppressive microenvironment in human bone metastatic prostate cancer enriched in exhausted T cells and orchestrated by myeloid cells overexpressing CCL20. Pharmacological or genetic targeting of the CCL20/CCR6 axes in an animal model relieves the immune-suppressive state and extends the survival of metastatic tumor bearing mice.
登录
查看更多内容
影响因子:
8
作者:
Fergusson JR;Hühn MH;Swadling L;Walker LJ;Kurioka A;Llibre A;Bertoletti A;Holländer G;Newell EW;Davis MM;Sverremark-Ekström E;Powrie F;Capone S;Folgori A;Barnes E;Willberg CB;Ussher JE;Klenerman P
通讯作者:
Klenerman P
DOI:
10.1073/pnas.1704958114
发表时间:
2017-11-21
影响因子:
11.1
作者:
Getschman, A. E.;Imai, Y.;Volkman, B. F.
通讯作者:
Volkman, B. F.
影响因子:
48
作者:
Barkas, Nikolas;Petukhov, Viktor;Kharchenko, Peter V.
通讯作者:
Kharchenko, Peter V.
影响因子:
--
作者:
Ikeda S;Kitadate A;Ito M;Abe F;Nara M;Watanabe A;Takahashi N;Miyagaki T;Sugaya M;Tagawa H
通讯作者:
Tagawa H
影响因子:
14.8
作者:
Efremova, Mirjana;Vento-Tormo, Miquel;Vento-Tormo, Roser
通讯作者:
Vento-Tormo, Roser